NCT05101070 2026-03-18
aCCeleR8-001
Shionogi Inc.
Phase 1/2 Recruiting
Clinical Trials
14 trialsNCT06885281 2026-02-13
A Study of ZL-1310 in Participants With Selected Solid Tumors
Zai Lab (Hong Kong), Ltd.
Phase 1/2 Recruiting
NCT03917381 2026-02-11
GEN1046 Safety Trial in Patients With Malignant Solid Tumors
Genmab
Phase 1/2 Active not recruiting
NCT04627740 2026-01-20
Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors
Xinqiao Hospital of Chongqing
Phase 1/2 Completed
NCT07265622 2025-12-29
First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Recruiting
NCT07105215 2025-11-26
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
RemeGen Co., Ltd.
Phase 1/2 Recruiting
NCT07055594 2025-11-06
NbTAST-01
Shine-On Biomedical Co., Ltd.
Phase 1/2 Recruiting
NCT06873789 2025-10-15
A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
Incyte Corporation
Phase 1/2 Active not recruiting
NCT07158918 2025-09-08
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
ABL Bio, Inc.
Phase 1/2 Recruiting
NCT04685226 2025-09-02
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2 Recruiting
NCT06992687 2025-05-28
A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 1/2 Enrolling by invitation
NCT06955390 2025-05-02
Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors
Henan Cancer Hospital
Phase 1/2 Not yet recruiting
NCT06947226 2025-04-27
A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06928363 2025-04-15
A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors.
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
Phase 1/2 Not yet recruiting